Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 9:01 AM ET

Date/Time Source News Release
06/03/2025 07:00 AM EDT PR Newswire Genprex to Participate at BIO 2025 International Convention
05/29/2025 07:00 AM EDT PR Newswire Genprex to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting
05/28/2025 07:00 AM EDT PR Newswire Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
05/07/2025 07:00 AM EDT PR Newswire Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes
05/06/2025 07:00 AM EDT PR Newswire Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Glioblastoma
04/30/2025 07:30 AM EDT PR Newswire Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting
04/29/2025 07:30 AM EDT PR Newswire Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
04/28/2025 07:30 AM EDT PR Newswire Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
04/24/2025 08:15 AM EDT PR Newswire Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting
04/22/2025 08:15 AM EDT PR Newswire Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings
Page

Additional News

As of June 9, 2025 • 9:01 AM ET

Date/Time Source News Release
05/14/2025 05:30 AM EDT US Earnings Reports Expected earnings - Genprex Inc.
04/28/2025 08:35 AM EDT 24/7 Market News Genprex Bolsters Oncology Portfolio with Exclusive NYU Langone License for Reqorsa Gene Therapy in Mesothelioma Treatment
04/28/2025 07:43 AM EDT SeekingAlpha Genprex enters patent license agreement with NYU Langone Health
04/06/2025 06:49 PM EDT KlickAnalytics GNPX - Historical Price Movements Surrounding Earnings
04/06/2025 06:44 PM EDT KlickAnalytics GNPX - Historical Earnings Price Analysis
11/23/2024 04:40 AM EST US Earnings Reports Expected earnings - Genprex Inc.
10/28/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Mon, Oct 28, 2024 as of 4:00 pm ET
10/23/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Oct 23, 2024 as of 10.00 am ET
10/22/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Oct 22, 2024 as of 4:00 pm ET
10/22/2024 11:11 AM EDT InvestorBrandNetwork Genprex Inc. (NASDAQ: GNPX) is One of Tuesday Morning's Most Active Stocks
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.